Banco Santander’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-14,129
Closed -$477K 367
2022
Q2
$477K Sell
14,129
-8
-0.1% -$280 0.01% 338
2022
Q1
$494K Sell
14,137
-2,732
-16% -$93.4K 0.01% 351
2021
Q4
$514K Sell
16,869
-7,270
-30% -$237K ﹤0.01% 360
2021
Q3
$791K Buy
24,139
+504
+2% +$16.1K ﹤0.01% 324
2021
Q2
$715K Buy
+23,635
New +$778K ﹤0.01% 303

Other funds holding OGN

Banco Santander's OGN Position: Q3 2022 in Review

Banco Santander sold out of Organon & Co (OGN) in Q3 2022, closing a stake of 14,129 shares — an estimated $477K sold.

Banco Santander first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $791K in Q3 2021. 791 funds tracked by Wall St. Rank hold OGN as of Q3 2022.

  • Banco Santander reported no remaining Organon & Co position as of Q3 2022 after selling out during the quarter.
  • Banco Santander sold 14,129 Organon & Co shares in Q3 2022, an estimated $477K.
  • Banco Santander first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
  • Banco Santander's Organon & Co position peaked at $791K in Q3 2021.
  • 791 funds tracked by Wall St. Rank held Organon & Co as of Q3 2022.

Based on Banco Santander's 13F filing for Q3 2022, filed 8 Nov 2022.